Affymetrix in Deal with MWG Biotech of Germany | GenomeWeb

Affymetrix of Santa Clara, Calif., said it has signed a licensing agreement with MWG-Biotech of Ebersberg, Germany, granting the German company the rights to certain Affymetrix intellectual property for commercializing low and medium density DNA arrays.

 

Under the terms of the license, MWG-Biotech has a non-exclusive, worldwide, royalty-bearing license that allows them to manufacture, use and sell low and medium density pre-spotted arrays.

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.